PrairieView Partners’s CVS Health CVS Stock Holding History

PrairieView Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$21K	Hold	310	–	–	﹤0.01%	239
2025 Q1	$21K	Hold	310	–	–	﹤0.01%	233
2024 Q4	$13K	Hold	310	–	–	﹤0.01%	267
2024 Q3	$19K	Hold	310	–	–	﹤0.01%	251
2024 Q2	$18K	Hold	310	–	–	﹤0.01%	258
2024 Q1	$25K	Hold	310	–	–	﹤0.01%	224
2023 Q4	$24K	Sell	310 -187	-38%	-$13.3K	﹤0.01%	224
2023 Q3	$34K	Sell	497 -18	-3%	-$1.27K	﹤0.01%	202
2023 Q2	$35K	Buy	515 +101	+24%	+$7.19K	﹤0.01%	221
2023 Q1	$30K	Hold	414	–	–	﹤0.01%	222
2022 Q4	$38K	Hold	414	–	–	0.01%	212
2022 Q3	$39K	Sell	414 -12	-3%	-$1.19K	0.01%	195
2022 Q2	$39K	Hold	426	–	–	0.01%	209
2022 Q1	$43K	Buy	426 +19	+5%	+$2K	0.01%	211
2021 Q4	$42K	Hold	407	–	–	0.01%	230
2021 Q3	$35K	Sell	407 -72	-15%	-$6.03K	0.01%	198
2021 Q2	$40K	Sell	479 -12	-2%	-$983	0.01%	184
2021 Q1	$37K	Sell	491 -2	-0.4%	-$146	0.01%	188
2020 Q4	$34K	Hold	493	–	–	0.01%	183
2020 Q3	$29K	Hold	493	–	–	0.01%	180
2020 Q2	$32K	Hold	493	–	–	0.01%	167
2020 Q1	$29K	Buy	+493	New	+$32.9K	0.01%	162

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PrairieView Partners's CVS Position: Q2 2025 in Review

PrairieView Partners held its CVS Health (CVS) position steady in Q2 2025 at 310 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #239.

PrairieView Partners first reported a position in CVS in Q1 2020 and has held it in 22 quarters since. The position peaked at $43K in Q1 2022. 1,757 funds tracked by Wall St. Rank hold CVS as of Q2 2025.

PrairieView Partners held 310 shares of CVS Health worth $21K as of Q2 2025.
PrairieView Partners left its CVS Health share count unchanged in Q2 2025.
CVS Health made up ﹤0.01% of PrairieView Partners's portfolio in Q2 2025, its #239 holding.
PrairieView Partners first reported a position in CVS Health in Q1 2020 and has held it in 22 quarters since.
PrairieView Partners's CVS Health position peaked at $43K in Q1 2022.
1,757 funds tracked by Wall St. Rank held CVS Health as of Q2 2025.

Based on PrairieView Partners's 13F filing for Q2 2025, filed 25 Jul 2025.